Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 TrialBernard Zinman, Kuninobu Takai, Stewart B. Harris et al.|Diabetes Care|2019Cited by 282
Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI studyTakeshi Osonoi, Makoto Katoh|Frontiers in Endocrinology|2025Cited by 2